The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Final results of EORTC intergroup randomized phase III trial comparing immediate versus deferred chemotherapy after radical cystectomy in patients with pT3T4 and/or N+ M0 transitional cell carcinoma (TCC) of the bladder.
Cora N. Sternberg
No relevant relationships to disclose
Iwona Anna Skoneczna
No relevant relationships to disclose
Jan M. Kerst
No relevant relationships to disclose
Sophie D. Fossa
No relevant relationships to disclose
Peter Albers
No relevant relationships to disclose
Mads Agerbaek
No relevant relationships to disclose
Herlinde Dumez
No relevant relationships to disclose
Maria De Santis
No relevant relationships to disclose
Christine Theodore
No relevant relationships to disclose
Michael Gordon Leahy
No relevant relationships to disclose
John D. Chester
No relevant relationships to disclose
Antony Verbaeys
No relevant relationships to disclose
Armelle Caty
No relevant relationships to disclose
Gedske Daugaard
No relevant relationships to disclose
Sandrine Marreaud
No relevant relationships to disclose
Samantha Cambier
No relevant relationships to disclose
Richard Sylvester
No relevant relationships to disclose